Hetlioz is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Vanda Pharmaceuticals Inc.. The primary component is Tasimelteon.
| Product ID | 43068-220_046bf85f-3017-415f-a709-4d849c8d2744 | 
| NDC | 43068-220 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Hetlioz | 
| Generic Name | Tasimelteon | 
| Dosage Form | Capsule | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2014-04-04 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA205677 | 
| Labeler Name | Vanda Pharmaceuticals Inc. | 
| Substance Name | TASIMELTEON | 
| Active Ingredient Strength | 20 mg/1 | 
| Pharm Classes | Melatonin Receptor Agonist [EPC],Melatonin Receptor Agonists [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2021-12-31 | 
| Marketing Start Date | 2014-04-04 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA205677 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2014-04-04 | 
| Ingredient | Strength | 
|---|---|
| TASIMELTEON | 20 mg/1 | 
| SPL SET ID: | ca4a9b63-708e-49e9-8f9b-010625443b90 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 43068-220 | Hetlioz | tasimelteon | 
| 43068-304 | Hetlioz | tasimelteon | 
| 0480-4490 | Tasimelteon | Tasimelteon | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() HETLIOZ  97791877  not registered Live/Pending  | 
        Vanda Pharmaceuticals Inc.  2023-02-13  | 
![]() HETLIOZ  88981892  not registered Live/Pending  | 
        Vanda Pharmaceuticals Inc.  2019-04-01  | 
![]() HETLIOZ  88366716  not registered Live/Pending  | 
        Vanda Pharmaceuticals Inc.  2019-04-01  | 
![]() HETLIOZ  85383242  4552099 Live/Registered  | 
        Vanda Pharmaceuticals Inc.  2011-07-28  |